Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intention to Utilise Over-allotment Facility

14 Mar 2024 13:00

RNS Number : 8959G
Baronsmead Second Venture Trust PLC
14 March 2024

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS.

Baronsmead SECOND Venture Trust plc

LEI: 2138008D3WUMF6TW8C28

14 March 2024

Announcement of Intention to Utilise Over-allotment Facility and Offer Update

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on 24 November 2023 that the Company, together with Baronsmead Venture Trust plc, had published a prospectus (the "Prospectus") in relation to offers for subscription to raise up to £30 million in aggregate with the discretion to utilise Over-allotment Facilities to raise up to a further £20 million in aggregate (the "Offers" and each an "Offer"). Full details of the Offer are contained in the Prospectus as supplemented by the supplementary prospectus dated 19 January 2024.

The Board is pleased to announce that, as of close of business on 13 March 2024, valid applications have been received for £12.25 million under the Company's Offer and therefore the initial amount is likely to be fully subscribed for shortly. On the basis of the deal pipeline, the Board has resolved that it is in the best interests of Shareholders to utilise the Over-allotment Facility and subscriptions will be accepted to raise up to an additional £10 million, subject to the terms of the Offer.

The first allotment of shares in respect of valid applications accepted by the Company took place on 26 January and the second allotment on 15 February 2024. The third allotment date is scheduled for 28 March 2024. As stated in the Prospectus, the fourth allotment will only take place if the Offer is not fully subscribed by 3 April 2024 and the Board decides to extend the period of the Offer.

All capitalised terms used and not defined herein shall have the same meaning as in the Prospectus.

For further information please contact:

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com

Important Information

This Announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This Announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Baronsmead Venture Trust plc or Baronsmead Second Venture Trust plc (together the "Companies") in any jurisdiction, including in or into Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA (other than any member state of the EEA where the Companies' securities may be lawfully marketed). Investors should not subscribe for or purchase any ordinary shares referred to in this Announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published on 24 November 2023 by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc, together with the supplementary prospectus published on 19 January 2024 (the "Supplementary Prospectus"), in connection with the Offer. A copy of the Prospectus and Supplementary Prospectus is available for inspection, subject to certain access restrictions, from the Company's registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website (http://www.baronsmeadvcts.co.uk). Approval of the Prospectus and Supplementary Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus and Supplementary Prospectus. Potential investors are recommended to read the Prospectus and Supplementary Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Companies' securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDFZLFFZXLLBBL
Date   Source Headline
2nd Aug 202112:42 pmRNSTotal Voting Rights
23rd Jul 20215:27 pmRNSTransaction in Own Shares
21st Jul 20219:30 amRNSNet Asset Value(s)
1st Jul 202110:29 amRNSTotal Voting Rights
9th Jun 20216:23 pmRNSTransaction in Own Shares
4th Jun 20216:00 pmRNSNet Asset Value(s)
27th May 20213:35 pmRNSHalf-year Report
7th May 20214:15 pmRNSNet Asset Value(s)
15th Apr 20215:00 pmRNSNet Asset Value(s)
1st Apr 202110:16 amRNSTotal Voting Rights
30th Mar 20216:01 pmRNSTransaction in Own Shares
18th Mar 20213:22 pmRNSIssue of New Shares
9th Mar 202112:03 pmRNSSale of shares from Treasury
3rd Mar 20215:15 pmRNSNet Asset Value(s)
2nd Mar 202112:41 pmRNSOffer for Subscription - Update
1st Mar 202112:43 pmRNSTotal Voting Rights
26th Feb 202111:26 amRNSIssue of New Shares
16th Feb 20215:14 pmRNSResult of AGM
15th Feb 20219:22 amRNSUpdate on Fundraising
5th Feb 202110:00 amRNSNet Asset Value(s)
1st Feb 202112:22 pmRNSTotal Voting Rights
29th Jan 20211:30 pmRNSIssue of New Shares
27th Jan 20215:30 pmRNSTransaction in Own Shares
27th Jan 202111:27 amRNSPublication of Supplementary Prospectus
21st Jan 20215:45 pmRNSNet Asset Value(s)
6th Jan 202110:37 amRNSUpdate on Fundraising
4th Jan 202112:05 pmRNSTotal Voting Rights
18th Dec 20207:00 amRNSIssue of Equity
17th Dec 20205:45 pmRNSTransaction in Own Shares
14th Dec 202012:27 pmRNSAppointment of Non-Executive Director
4th Dec 20204:15 pmRNSNet Asset Value(s)
3rd Dec 20206:00 pmRNSAnnual Financial Report For Y/E 30/09/20
1st Dec 202010:37 amRNSTotal Voting Rights
27th Nov 20201:05 pmRNSCorrection: Directorate Change
25th Nov 20203:51 pmRNSDirectorate Change
10th Nov 20203:08 pmRNSDirector/PDMR Shareholding
10th Nov 20202:58 pmRNSDirector/PDMR Shareholding
10th Nov 20202:44 pmRNSDirector/PDMR Shareholding
10th Nov 20202:41 pmRNSDirector/PDMR Shareholding
10th Nov 20201:44 pmRNSIssue of New Shares
5th Nov 20201:00 pmRNSNet Asset Value(s)
2nd Nov 202011:15 amRNSTotal Voting Rights
27th Oct 20203:51 pmRNSTransaction in Own Shares
20th Oct 20207:00 amRNSNet Asset Value(s)
14th Oct 202011:01 amRNSManagement Engagement & Remuneration Committee
7th Oct 20205:10 pmRNSOffer update – Extension of Earlybird Rebate
1st Oct 202011:00 amRNSTotal Voting Rights
29th Sep 202011:22 amRNSTransaction in Own Shares
17th Sep 20209:00 amRNSPublication of a Prospectus
11th Sep 20204:44 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.